17 α-hydroxyprogesterone caproate (Makena®): a guide to its use in the prevention of preterm birth.
作者： Mary Hines , Katherine A. Lyseng-Williamson , Emma D. Deeks
DOI: 10.1007/S40261-013-0060-6
关键词:
摘要: Intramuscular 17 α-hydroxyprogesterone caproate (Makena®), a synthetic progestin, is indicated to reduce the risk of preterm birth in women with singleton pregnancy who have history spontaneous birth. Makena® reduces this patient population, and associated improvements certain fetal/neonatal outcomes. The use US FDA-approved formulation inherent risks pharmacy-compounded formulations drug.
springer.com
sci-hub.se 参考文章(41)
John W.C. Johnson, Peter A. Lee, Annelies S. Zachary, Shirley Calhoun, Claude J. Migeon, High-risk prematurity--progestin treatment and steroid studies. Obstetrics & Gynecology. ,vol. 54, pp. 412- 418 ,(1979)
Vincenzo Berghella, Progesterone and Preterm Birth Prevention: Translating Clinical Trials Data into Clinical Practice ,(2012)
Nafiseh Saghafi, Nayereh Khadem, Taraneh Mohajeri, Mohamad Taghi Shakeri, Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery. Journal of Obstetrics and Gynaecology Research. ,vol. 37, pp. 1342- 1345 ,(2011) , 10.1111/J.1447-0756.2011.01524.X
Steve N Caritis, Shringi Sharma, Raman Venkataramanan, Dwight J Rouse, Alan M Peaceman, Anthony Sciscione, Catherine Y Spong, Michael W Varner, Fergal D Malone, Jay D Iams, Brian M Mercer, John M Thorp Jr, Yoram Sorokin, Marshall Carpenter, Julie Lo, Susan Ramin, Margaret Harper, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation. American Journal of Obstetrics and Gynecology. ,vol. 205, pp. 40- ,(2011) , 10.1016/J.AJOG.2011.03.028
Mathias Onsrud, Elisabeth Paus, Egil Haug, Kjell K Ørstad, Intramuscular Administration of Hydroxyprogesterone Caproate in patients with Endometrial Carcinoma: Pharmacokinetics and effects on adrenal function Acta Obstetricia et Gynecologica Scandinavica. ,vol. 64, pp. 519- 523 ,(1985) , 10.3109/00016348509156732
Josephine Amory, Richard Lawler, Laurence Shields, Hydroxyprogesterone caproate and progesterone increase tumor necrosis factor-alpha production in lipopolysaccharide stimulated whole blood from non-pregnant women Journal of Perinatal Medicine. ,vol. 33, pp. 506- 509 ,(2005) , 10.1515/JPM.2005.089
Fabio Facchinetti, Giulia Dante, Paolo Venturini, Simone Paganelli, Annibale Volpe, 17α-Hydroxy-Progesterone Effects on Cervical Proinflammatory Agents in Women at Risk for Preterm Delivery American Journal of Perinatology. ,vol. 25, pp. 503- 506 ,(2008) , 10.1055/S-0028-1085071
Moustafa Ibrahim, Ahmed Ramy Mohamed Ramy, Moustafa Abdel-Fattah Younis, None, Progesterone supplementation for prevention of preterm labor: A randomized controlled trial Middle East Fertility Society Journal. ,vol. 15, pp. 39- 41 ,(2010) , 10.1016/J.MEFS.2010.03.007
John L. Chollet, Michael J. Jozwiakowski, Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection Drug Development and Industrial Pharmacy. ,vol. 38, pp. 540- 549 ,(2012) , 10.3109/03639045.2012.662511
A. Rebarber, N. B. Istwan, K. Russo-Stieglitz, J. Cleary-Goldman, D. J. Rhea, G. J. Stanziano, D. H. Saltzman, Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery Diabetes Care. ,vol. 30, pp. 2277- 2280 ,(2007) , 10.2337/DC07-0564